Ads
related to: merck & co inc stock pricedirexion.com has been visited by 100K+ users in the past month
- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- Pharma ETF
Direxion Pharma & Medical ETF
Daily Bull 3X Shares - PILL
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- Education
Articles, videos & tools to help
understand Leveraged ETFs and more.
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- Bull & Bear 3X ETFs
Search results
Analysts Set Merck & Co., Inc. (NYSE:MRK) Price Target at $131.25
ETF DAILY NEWS· 7 days agoMerck & Co., Inc. (NYSE:MRK – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve research firms ...
Q3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)
ETF DAILY NEWS· 7 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 earnings per share estimates for ...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 2 days agoOn Friday, Wells Fargo adjusted its outlook on shares of pharmaceutical giant Merck & Co., Inc....
What Direction Does Merck & Co Inc (NYSE: MRK) Analysts Think The Company Will Take? – Stocks...
Stocks Register· 5 days agoThe trading price of Merck & Co Inc (NYSE:MRK) remained unchanged on Tuesday, April 23, closing at $126.88. The company ...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 3 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 3 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Analysts review Merck & Co Inc’s rating – Knox Daily
Knox Daily· 7 days agoHe buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential. We...owns ...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 3 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt
Simply Wall St. via Yahoo Finance· 3 days agoWe can see that Merck & Co., Inc. (NYSE:MRK) does use debt in its business. But the more important...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 3 days agoIn the past year, the stock has gained 9% compared with the industry’s 15.7% rise. Image Source:...
